Clinical Trial Update: Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT) [Phase 3]

View source ↗

Summary

Long-term follow-up and lenalidomide maintenance therapy results from a Phase 3 trial in multiple myeloma (BMT CTN 0702).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2020-05-11